Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viability.

The Prostate

Volumn 70, Issue 16, 2010, Pages 1799-1808

  Morrissey, Colm ^a   Dowell, Alex ^b   Koreckij, Theodore D ^b   Nguyen, Holly ^b   Lakely, Bryce ^b   Fanslow, William C ^b   True, Lawrence D ^b   Corey, Eva ^b   Vessella, Robert L ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; PRIMER DNA; PROSTATE SPECIFIC ANTIGEN;

ANIMAL; ARTICLE; BLOOD; BONE TUMOR; CELL DIVISION; CELL SURVIVAL; DRUG ANTAGONISM; GENETICS; HUMAN; MALE; MICROCIRCULATION; MOUSE; MOUSE MUTANT; PATHOLOGY; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATE TUMOR; RADIOGRAPHY; SKIN TUMOR; TIBIA; VASCULARIZATION; XENOGRAFT;

ANGIOPOIETIN-2; ANIMALS; BONE NEOPLASMS; CELL DIVISION; CELL SURVIVAL; DNA PRIMERS; HUMANS; MALE; MICE; MICE, SCID; MICROCIRCULATION; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTOR, TIE-2; SKIN NEOPLASMS; TIBIA; TRANSPLANTATION, HETEROLOGOUS;

EID: 78349290859     PISSN: None     EISSN: 10970045     Source Type: Journal    
DOI: None     Document Type: Article

References (0)